Akston launches clinical trial for novel canine cancer therapy | dvm360
Akston Launches Clinical Trial for Novel Canine Cancer Therapy Akston Biosciences Corporation has partnered with Purdue University to develop a drug targeting PD-L1 in dogs with solid tumo…